{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,17]],"date-time":"2023-10-17T05:40:35Z","timestamp":1697521235969},"reference-count":3,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2007,2,20]],"date-time":"2007-02-20T00:00:00Z","timestamp":1171929600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cytometry Part B Clinical"],"published-print":{"date-parts":[[2007,9]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>We observed inhibition of anti\u2010CD45, but not anti\u2010CD3, \u2010CD4, or \u2010CD8 staining in the whole blood of an individual clinical specimen. Subsequent experiments demonstrated the presence of a plasma factor, which likewise blocked CD45 staining of third party lymphocytes. The blocking activity was anti\u2010CD45 clone (2D1) specific. Experiments utilizing immunoabsorption, immunofluorescence, and commercial blocking reagents failed to provide evidence for identifying blocking factor as heterophilic antibody. Biochemical identification of blocking factor was not accomplished. \u00a9 2007 Clinical Cytometry Society.<\/jats:p>","DOI":"10.1002\/cyto.b.20168","type":"journal-article","created":{"date-parts":[[2007,2,20]],"date-time":"2007-02-20T23:46:28Z","timestamp":1172015188000},"page":"423-426","source":"Crossref","is-referenced-by-count":0,"title":["Clone\u2010specific anti\u2010CD45 blocking factor in patient plasma"],"prefix":"10.1002","volume":"72B","author":[{"given":"Samuel R.","family":"Wellhausen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen P.","family":"Slone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James J.","family":"Miller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2007,8,14]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1373\/clinchem.2004.042994","article-title":"The War on heterophilic antibody interference","volume":"52","author":"Bjerner J","year":"2005","journal-title":"Clin Chem"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1373\/clinchem.2004.042523"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1177\/107327480200900207"}],"container-title":["Cytometry Part B: Clinical Cytometry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fcyto.b.20168","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/cyto.b.20168","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,16]],"date-time":"2023-10-16T18:07:20Z","timestamp":1697479640000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/cyto.b.20168"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,8,14]]},"references-count":3,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2007,9]]}},"alternative-id":["10.1002\/cyto.b.20168"],"URL":"https:\/\/doi.org\/10.1002\/cyto.b.20168","archive":["Portico"],"relation":{},"ISSN":["1552-4949","1552-4957"],"issn-type":[{"value":"1552-4949","type":"print"},{"value":"1552-4957","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,8,14]]}}}